Medicon Valley in world-class

Medicon Valley holds a strong position in the international competition to attract biotech investments assigned to regions with universities having world-class research and an important composition of small biotech as well as large pharmaceutical companies.

For the first time ever, an analysis shows the research areas in which Medicon Valley has its unique competencies making it possible to attract investments and research talents to the region. The survey titled “Commercial Attractiveness of Biomedical R&D in Medicon Valley” is the first of its kind combining analysis of the quality of the research in the region with a purely commercial perspective.

A Copenhagen Capacity initiated survey

The survey of Medicon Valley’s research is made by the worldwide consultancy company The Boston Consulting Group (BCG) for Copenhagen Capacity and Region Skåne Inward Investment.

Copenhagen Capacity and Region Skåne are promoting Medicon Valley globally and contributing to the development of region in the biomedical area.

The highlights

Among the survey's highlights are:

• Medicon Valley’s research is world-class particularly within four large commercially attractive areas
• Medicon Valley has a unique company strucuture with an attractive technology profile

Have a copy of the survey

You can download the report "Commercial Attractiveness of Biomedical R&D in Medicon Valley” in a pdf-format here.

You can order a copy of the report here.

Furhermore, you can download a special edition of Medicon Valley Biomedical Newsletter with a short version of the report here. 

Further information

For further information about the survey, you are also welcome to contact business development manager Ruth Klyver Jørgensen at Copenhagen Capacity.

You can read more abouth the life science industry in Copenhagen and the Øresund region - the Medicon Valley  - here.

Last updated on: 05-11-2007	<< Back   Top